Arpeggio Bio

OverviewSuggest Edit

Arpeggio Bio is a company that provides biological assay and machine learning algorithms enabling high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.

Latest Updates

Employees (est.) (Apr 2021)10
Cybersecurity ratingAMore

Key People/Management at Arpeggio Bio

Joey Azofeifa

Joey Azofeifa

Founder, CEO
Laura Norris

Laura Norris

Tim Read

Tim Read

Founder, Drug Discovery
Joe McMahon

Joe McMahon

Show more

Arpeggio Bio Financials and Metrics

Summary Metrics

Founding Date


Arpeggio Bio total Funding

$3.4 m

Arpeggio Bio latest funding size

$3.2 m

Time since last funding

a year ago

Arpeggio Bio investors

Arpeggio Bio's latest funding round in January 2020 was reported to be $3.2 m. In total, Arpeggio Bio has raised $3.4 m
Show all financial metrics

Arpeggio Bio Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Arpeggio Bio Online and Social Media Presence

Embed Graph

Arpeggio Bio Frequently Asked Questions

  • When was Arpeggio Bio founded?

    Arpeggio Bio was founded in 2017.

  • Who are Arpeggio Bio key executives?

    Arpeggio Bio's key executives are Joey Azofeifa, Laura Norris and Tim Read.

  • How many employees does Arpeggio Bio have?

    Arpeggio Bio has 10 employees.

  • Who are Arpeggio Bio competitors?

    Competitors of Arpeggio Bio include TissueTech, DeepCure and Blazer.